In this article
MEDVi’s published support number is (323) 690-1564. Its published support email is help@medvi.org.
These contact details come from MEDVi’s own published material, linked below. This page is a reference guide from Is X Legit; we are not MEDVi and cannot access patient accounts. Check the official page again before sharing personal information.
MEDVi’s published support number is (323) 690-1564. Its published support email is help@medvi.org.
What to know first
- MEDVi’s QUAD page separately lists (585) 312-4226. Pharmacy telephone numbers also appear in the footer; those are not the general MEDVi support line.
- Use a signed-in clinical channel for private treatment information.
- A listed support channel is not a promise of response time or prescribing access.
The verified contact routes
Published telephone: (323) 690-1564.
Published email: help@medvi.org.
MEDVi’s QUAD page separately lists (585) 312-4226. Pharmacy telephone numbers also appear in the footer; those are not the general MEDVi support line.
The official website and patient login
Start with the official MEDVi website. Follow its current account or contact link. We have not verified a separate permanent patient-login address for publication here.
If a bookmarked page stops working, return to the official site instead of selecting a sponsored search result or entering your password into a lookalike address. We do not ask for your password, a one-time code, or a payment card. A service may legitimately use another domain for its portal; the link from its own site is the evidence to check.
Billing, shipping, or a medical question?
For a charge or renewal, ask the administrative team to identify the plan and transaction. The MEDVi pricing guide explains the items to compare. For a shipment, provide your order number and ask whether the prescription is awaiting approval, at the pharmacy, or already with the carrier.
MEDVi’s current public footer lists Triad Rx, Red Rock, and Beaker among its pharmacy partners. A partner list does not identify which pharmacy will fill a particular patient’s order or verify its authority to ship into that patient’s state. A pharmacist is the appropriate contact for a product label, storage condition, or measuring instruction. Your prescribing clinician is the appropriate contact for a treatment decision. Ask support to route the issue rather than accepting a general sales answer as clinical advice.
If you cannot get into the account
Use the reset or account-recovery link reached from the official site. Check that you are using the email or phone associated with the original purchase, and look in spam for a reset message. Avoid repeatedly creating new accounts: that can separate the order history from the account you are trying to recover.
If recovery fails, use the verified MEDVi contact route above and describe the error without sending a password or security code. Ask for an account-recovery process. We have not tested access to a private patient account and do not claim that login will work for a specific patient.
If the reason for contact is cancellation
The main site links to terms and a refund policy. Some linked legal destinations did not load successfully during this research, so we cannot certify their current contents. Ask support for a working policy URL or a copy of the terms before committing to a prepaid plan.
Our MEDVi cancellation guide explains what to ask. Keep a dated record of your request and the response. For general evaluation of the service, return to the MEDVi review.
Sources & research notes
Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.
- MEDVi: provider, pharmacy, and contact disclosuresProvider-published information · Checked September 21, 2026
- FDA: MEDVi warning letter, February 20, 2026Regulatory / public agency · Checked September 21, 2026
- MEDVi QUAD: product and ingredient pageProvider-published information · Checked September 21, 2026
Read our methodology · Commercial disclosure · Request a correction